The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
The US-based Australian sleep apnoea device giant has exceeded expectations with strong second quarter numbers.
Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...
Smartphones are taking a shot at slenderizing in a nod to Ben Stiller’s itty-bitty mobile in the early-aughts classic ...
Of late, there have been many questions about maintaining weight loss after using Ozempic (semaglutide) and whether the process kick-started by the drug can be sustainable in the long run. Ozempic ...
Semaglutide (known by its brandname Ozempic) has gained widespread attention for its weight loss benefits, but is officially approved for managing type 2 diabetes. While there is currently ...
Between 3% and 5% of colorectal cancers exhibit the KRAS G12C mutation. Credit: SewCreamStudio/Shutterstock. Amgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab ...
Weight loss drugs like Zepbound and Novo Nordisk's Ozempic aren't covered under Medicare, but can be covered when prescribed to treat another disease like sleep apnea. The Biden administration ...
Having made waves the world over, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly’s tirzepatide are set to enter the Indian ...
Dec. 14, 2023. (AP Photo/Andrew Harnik, File) The injectable drug Ozempic is shown, July 1, 2023, in Houston. (AP Photo/David J. Phillip, File) A dosage of Wegovy, March 1, 2024 in Front Royal, Va.
WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...
WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...